col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Indian Drug Manufacturers' Association (IDMA)

11 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] INDIAN DRUGS 2024―Mar―18 COMPUTATIONAL IDENTIFICATION OF SELECTED BIOACTIVE COMPOUNDS FROM CEDRUS DEODARA AS INHIBITORS AGAINST SARS-COV-2 MAIN PROTEASE: A PHARMACOINFORMATICS STUDY Aminabee Shaik, Lakshmana Rao Atmakuri
2 [GO] INDIAN DRUGS 2024―Mar―18 PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY Jackson A. Pereira, Eduardo D. Costa
3 [GO] INDIAN DRUGS 2024―Feb―23 LIVING WITH THE GHOST: CAN WE EVER ESCAPE COVID-19’S SHADOW? Prof. (Dr.) Pooja A Chawla
4 [GO] INDIAN DRUGS 2023―Jun―07 CORONAVIRUS DISEASE 2019 (COVID-19): PUBLIC HEALTH EMERGENCY Babita Sarangi, Jyotirmaya Sahoo, Utpal Jana, Guru P. Mohanta
5 [GO] INDIAN DRUGS 2022―Sep―23 POSSIBLE DESTRUCTION OF SARS-COV-2 BY SODIUM DEOXYCHOLATE Durga Pandey, Deepti Jain, Girijesh Pandey, Surendra Jain
6 [GO] INDIAN DRUGS 2022―Feb―28 RNA BASED THERAPIES - A POSITIVE OUTCOME OF COVID-19 George Patani
7 [GO] INDIAN DRUGS 2021―Sep―24 PANDEMIC AND “INFODEMIC” Nagaraj Rao
8 [GO] INDIAN DRUGS 2021―Sep―23 PHARMACEUTICAL EDUCATION AND RESEARCH: POST THE COVID-19 PANDEMIC George Patani
9 [GO] INDIAN DRUGS 2021―Sep―23 SPICES, COVID-19 AND LOW HANGING FRUITS FOR THE PHARMACEUTICAL INDUSTRY D B Anantha Narayana
10 [GO] INDIAN DRUGS 2021―Sep―21 COVID-19: NEW PARADIGMS FOR DISEASE MANAGEMENT Vandana B. Patravale
11 [GO] INDIAN DRUGS 2021―Sep―20 CHALLENGING COVID-19 Nagaraj N. Rao
 [1] 

11 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec